Nihar Bhakta

788 total citations
12 papers, 535 citations indexed

About

Nihar Bhakta is a scholar working on Nephrology, Rheumatology and Surgery. According to data from OpenAlex, Nihar Bhakta has authored 12 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Nephrology, 7 papers in Rheumatology and 3 papers in Surgery. Recurrent topics in Nihar Bhakta's work include Gout, Hyperuricemia, Uric Acid (9 papers), Urticaria and Related Conditions (5 papers) and Case Reports on Hematomas (3 papers). Nihar Bhakta is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (9 papers), Urticaria and Related Conditions (5 papers) and Case Reports on Hematomas (3 papers). Nihar Bhakta collaborates with scholars based in United States, New Zealand and France. Nihar Bhakta's co-authors include Scott Baumgartner, Maple M. Fung, Chris Storgard, Jeff Kopicko, Scott Adler, Kenneth G. Saag, Nicola Dalbeth, Michael A. Becker, David Fitzpatrick and Thomas Bardin and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Nihar Bhakta

11 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nihar Bhakta United States	9	505	380	217	92	75	12	535
Jeff Kopicko United States	7	502 1.0×	379 1.0×	215 1.0×	90 1.0×	74 1.0×	10	510
Kathleen Brewer United States	4	360 0.7×	259 0.7×	182 0.8×	43 0.5×	68 0.9×	6	398
Emvalee Arromdee Thailand	6	263 0.5×	124 0.3×	141 0.6×	72 0.8×	42 0.6×	9	347
Caroline van Durme Netherlands	8	202 0.4×	106 0.3×	102 0.5×	33 0.4×	9 0.1×	17	250
À. Risso Italy	7	33 0.1×	109 0.3×	71 0.3×	59 0.6×	147 2.0×	13	349
Rachele Brugnano Italy	8	174 0.3×	28 0.1×	38 0.2×	31 0.3×	30 0.4×	13	270
Pornrith Pisuttimarn Thailand	4	57 0.1×	44 0.1×	170 0.8×	107 1.2×	7 0.1×	6	325
Janitzia Vázquez Mellado Mexico	5	105 0.2×	61 0.2×	75 0.3×	9 0.1×	10 0.1×	8	132
D. C. Winter Ireland	8	56 0.1×	199 0.5×	20 0.1×	20 0.2×	4 0.1×	13	294
Mohamad Hanouneh United States	9	39 0.1×	51 0.1×	17 0.1×	18 0.2×	117 1.6×	32	254

Countries citing papers authored by Nihar Bhakta

Since Specialization

Citations

This map shows the geographic impact of Nihar Bhakta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nihar Bhakta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nihar Bhakta more than expected).

Fields of papers citing papers by Nihar Bhakta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nihar Bhakta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nihar Bhakta. The network helps show where Nihar Bhakta may publish in the future.

Co-authorship network of co-authors of Nihar Bhakta

This figure shows the co-authorship network connecting the top 25 collaborators of Nihar Bhakta. A scholar is included among the top collaborators of Nihar Bhakta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nihar Bhakta. Nihar Bhakta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Bissonnette, Robert, et al.. (2021). A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis. Dermatology and Therapy. 11(6). 2179–2193. 10 indexed citations

Ortega, Héctor, Mary Fitzgerald, Nihar Bhakta, Kartik Raghupathi, & David Singh. (2019). Reduction of Exhaled Nitric Oxide by the DP2 antagonist GB001 in Patients with Mild Atopic Asthma.. Journal of Allergy and Clinical Immunology. 143(2). AB104–AB104.

Tausche, Anne‐Kathrin, Rieke Alten, Nicola Dalbeth, et al.. (2017). Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study. Lara D. Veeken. 56(12). 2170–2178. 88 indexed citations

Dalbeth, Nicola, Graeme Jones, Robert Terkeltaub, et al.. (2017). Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial. Arthritis & Rheumatology. 69(9). 1903–1913. 121 indexed citations

Bardin, Thomas, Robert T. Keenan, Puja Khanna, et al.. (2016). Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study). Annals of the Rheumatic Diseases. 76(5). 811–820. 126 indexed citations

Saag, Kenneth G., David Fitzpatrick, Jeff Kopicko, et al.. (2016). Lesinurad Combined With Allopurinol: A Randomized, Double‐Blind, Placebo‐Controlled Study in Gout Patients With an Inadequate Response to Standard‐of‐Care Allopurinol (a US‐Based Study). Arthritis & Rheumatology. 69(1). 203–212. 135 indexed citations

Saag, Kenneth G., Michael A. Becker, Chris Storgard, et al.. (2016). THU0495 Examination of Serum Uric Acid (Sua) Lowering and Safety with Extended Treatment with Lesinurad and Allopurinol in Subjects with Gout. Annals of the Rheumatic Diseases. 75. 371–371. 4 indexed citations

Bardin, Thomas, Robert T. Keenan, Puja Khanna, et al.. (2015). FRI0333 Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination with Allopurinol: Results from a Phase III Study in Gout Patients Having an Inadequate Response to Standard of Care (Clear 2). Annals of the Rheumatic Diseases. 74. 545–545. 8 indexed citations

Dalbeth, Nicola, Graeme Jones, Robert Terkeltaub, et al.. (2015). SAT0329 Lesinurad, A Novel Selective Uric Acid Reabsorption Inhibitor, in Combination with Febuxostat, in Patients with Tophaceous Gout: the Crystal Phase III Clinical Trial. Annals of the Rheumatic Diseases. 74. 778–778. 13 indexed citations

10.

Tausche, Anne‐Kathrin, Rieke Alten, Nicola Dalbeth, et al.. (2015). SAT0307 Lesinurad Monotherapy in Gout Patients Intolerant to Xanthine Oxidase Inhibitors (Light): A Randomized, Double-Blind, Placebo-Controlled, 6-Month Phase III Clinical Trial. Annals of the Rheumatic Diseases. 74. 769–769. 2 indexed citations

11.

Saag, Kenneth G., David Fitzpatrick, Jeff Kopicko, et al.. (2015). FRI0320 Lesinurad, A Selective URIC Acid Reabsorption Inhibitor, in Combination with Allopurinol: Results from a Phase III Study in Gout Patients Having an Inadequate Response to Standard of Care (Clear 1). Annals of the Rheumatic Diseases. 74. 540–540. 10 indexed citations

12.

Bhakta, Nihar, Jennifer Marik, Mohammad Malekzadeh, David Gjertson, & Robert B. Ettenger. (2008). Can pediatric steroid‐free renal transplantation improve growth and metabolic complications?. Pediatric Transplantation. 12(8). 854–861. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact